Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Conclusion: In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Japan ,United States ,Itaja ,Goiábr ,Brazil ,Nile ,Washington ,Venezuela ,Venezuelan ,Japanese ,Brazilian ,Fernando Carlos Proen ,Luizo Assagra ,Fernando Baldi ,Juanj Chamie Quintero ,Lucy Kerr ,Raysildob Lobo ,Flavioa Cadegiani ,Jennifera Hibberd ,Pierre Kory ,Brazilian Health Regulatory Agency ,European Medicines Agency ,Council Of Medicine ,Washington Luiz ,West Nile ,Nacional De Vigil ,Medical Code ,Brazilian Board ,Medical Doctors ,Federal Council ,Conselho Federal De Medicina ,Santa Catarina ,